Energy Stock Powering Up 9% on $11.5B Buyout

An energy stock is surging due to an $11.5B buyout deal, a vaccine maker is up 11% after getting approval for its COVID-19 vaccines, and a tiny biotech stock is jumping 51% on fresh ALS trial data and FDA momentum. Read on to find out more.

High-Probability Trades (Sponsored)

Exposed: 5 Free Cheatsheets That Top Traders Swear By!

High-probability trades start with proven patterns—and these 5 laminated cheatsheets make them easy to find and follow.

Each pattern has a backtested track record of up to 90% win rates.

These tools are built to help traders remove emotion, time their entries, and approach the market with more precision.

Available now for free—limited quantity remaining.

[Click Here to Grab All 5 Cheatsheets]

*The profits and performance shown are not typical and you may lose money. We make no future earnings claims. All trades expressed are from historical, backtested data in order to demonstrate the potential of the system.

Futures 📈

What to Watch

Earnings:

• Trip.com Group Limited [TCOM]: Aftermarket

• Qifu Technology, Inc [QFIN]: Aftermarket

• Agilysys, Inc. [AGYS]: Aftermarket

• FS Credit Opportunities Corp. [FSCO]: Aftermarket

• Yalla Group Limited [YALA]: Aftermarket

Economic Reports:

• New York Fed President John Williams speech: 8:45 AM

• Fed Vice Chair Philip Jefferson speech: 8:45 AM

• U.S. leading economic indicators [April]: 10:00 AM

Free Report (Sponsored)

Capitalize on Policy-Backed Trends

Big policy shifts often lead to big market winners. A new investor report reveals 6 stocks positioned to benefit most under the current administration.

These companies could be at the center of capital flows, regulation tailwinds, and sector expansion.

Past picks from this strategy have shown potential for triple-digit gains.

[Download the Report Free]

(By submitting your email, you’ll also get a free Profit from the Pros membership, which highlights exclusive market updates and daily Strong Buy stocks. You can unsubscribe at any time.)

Biopharma

Novavax Gets Long-Awaited FDA Nod, Triggers Stock Surge

Novavax (NASDAQ: NVAX) is surging 11% in premarket trading today after the U.S. Food and Drug Administration granted long-awaited approval of its COVID-19 vaccine, Nuvaxovid, though with usage restrictions.

The FDA authorized the protein-based vaccine for individuals aged 12 and up who are at increased risk from COVID-19, including older adults and those with underlying health conditions.

The decision ends a prolonged wait for Novavax, which struggled with regulatory delays and manufacturing challenges during the height of the pandemic.

Unlike mRNA-based competitors from Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE), Novavax’s more traditional approach failed to capitalize on early vaccine demand.

The approval also activated a $175 million milestone payment from Sanofi (NASDAQ: SNY), stemming from a licensing deal signed in 2024.

Novavax plans to begin commercial distribution of the shot this fall in partnership with Sanofi, pending final strain recommendations from FDA advisers.

Despite the jump, Novavax shares remain down 16.3% year-to-date through the previous close, underscoring continued investor caution as the company attempts a late-stage comeback in the COVID vaccine market.

Energy

TXNM Shares Jump on Blackstone Takeover Agreement

TXNM Energy (NASDAQ: TXNM) announced its acquisition by Blackstone Infrastructure this morning. Blackstone Infrastructure is a unit of Blackstone Inc. (NYSE: BX).

The transaction will value the company at $11.5 billion, including debt and preferred equity. Following the announcement, TXNM shares are up 9.2% in premarket trading. Shares of Blackstone are slightly down by 1.8%.

Under the terms of the agreement, Blackstone will purchase TXNM for $61.25 per share in an all-cash deal. In addition, Blackstone will invest $400 million through a private placement, acquiring 8 million newly issued TXNM shares at $50 each.

The energy firm also plans to issue another $400 million in equity before the deal’s completion.

Leadership changes will accompany the acquisition, with Executive Chair Pat Collawn set to retire. Don Tarry will take the helm as president and CEO, continuing to lead TXNM through its next phase.

The merger is expected to close in the second half of 2026, pending shareholder and regulatory approvals.

AI (Sponsored)

The AI Shift Is Real—These Stocks May Benefit First

AI’s capabilities are growing rapidly—handling layered conversations, correcting itself, and adapting in real time.

This shift is opening up new frontiers for early investors.

A free report just revealed 5 high-potential stocks—including one under-the-radar name with breakout potential.

These tickers are positioned to ride the AI boom in its most advanced form yet.

[See the Top 5 AI Stocks – Free Access]

(By submitting your email address, you will receive a free subscription to the Profit From The Pros e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time.)

Logistics

ZIM Beats Q1 Expectations as Volume and Freight Rates Surge

ZIM Integrated Shipping Services (NYSE: ZIM) stock is rising 3% in premarket trading after reporting better-than-expected first-quarter earnings and revenue.

The Israeli shipping firm reported adjusted earnings per share of $2.45, well above the $1.74 consensus estimate. Revenue rose 28% year-over-year to $2.01 billion, beating projections of $1.82 billion.

The performance was driven by a 12% increase in carried volume, totaling 944,000 twenty-foot equivalent units (TEUs), and a 22% rise in average freight rates to $1,776 per TEU.

CEO Eli Glickman attributed the strong start to the company’s restructured fleet and cost discipline, noting that ZIM’s improved operational model helped it generate net income of $296 million in the quarter.

ZIM reaffirmed its full-year 2025 outlook, guiding for adjusted EBITDA between $1.6 billion and $2.2 billion, and adjusted EBIT in the range of $350 million to $950 million.

The company also declared a quarterly dividend of $0.74 per share, which represents roughly 30% of Q1 net income.

Movano Inc. [MOVE] - Last Close: $1.02

Movano Inc. is a health technology company developing wearable medical devices, including the Evie Ring, which provides health metrics tailored for women.

The firm’s stock has declined over 85% in the past year, recently hitting a 52-week low of $0.71. Today’s 26% surge in premarket trading is due to the company's announcement of exploring strategic alternatives, including a potential sale or merger.

Brainstorm Cell Therapeutics Inc. [BCLI] - Last Close: $1.32

Brainstorm Cell Therapeutics is a biotech company developing cell therapies for neurodegenerative diseases, including its NurOwn® platform for ALS and PMS.

The stock is gaining 51% in premarket trading after Brainstorm highlighted progress in discussions with the FDA and promising data from its NurOwn® trials, signaling potential regulatory traction.

Sable Offshore Corp. [SOC] - Last Close: $28.86

Sable Offshore Corp. is an independent oil and gas company focused on offshore California production.

Despite posting a $617 million net loss in 2024 due to non-cash charges and restart costs, the company reported $78 million in Q1 2025 revenue, surpassing analyst expectations.

The stock is up over 16% in premarket trading following the restart of production at the Santa Ynez Unit, with oil output reaching 6,000 barrels per day.

Trading Strategy (Sponsored)

Know your winning odds before you place any stock trade

Imagine knowing the historic win rate of a trade before placing it—70%, 80%, even 90%+.

These FIVE Candlestick Pattern Cheatsheets reveal high-probability setups and help identify precise entry and exit points.

Backtested and simplified for real-world trading, these tools are designed to reduce emotion and increase confidence.

They’re now available for free, while supplies last.

[Claim Your Free Candlestick Cheatsheets]

*The profits and performance shown are not typical and you may lose money. We make no future earnings claims. All trades expressed are from historical, backtested data in order to demonstrate the potential of the system.

Everything Else

• A US credit downgrade rattles markets and sparks flight to gold.

• Britain and EU finalize a wide-ranging pact to ease trade, travel, and security tension.

• Chinese manufacturing shows resilience, but consumer confidence remains shaky.

• Former president Joe Biden’s prostate cancer diagnosis reignites questions about age, leadership, and longevity.

• Investors tap brakes on the rally in Indian defense stocks as valuations raise red flags.

• Xiaomi doubles down on its chip ambitions with a massive 50 billion yuan pledge.

• Ryanair's profits slip despite record travel as weaker fares drag earnings.

• Nvidia reverses course with a potential leap into PsiQuantum’s $6 billion play.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

*Standard message/carrier rates may apply.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.